Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Biologic dmards----1件: 107 💬
2Biological dmards----2件: 86, 107 💬
3Classic dmards treatment group----1件: 46 💬
4CO-medication: synthetic dmards----1件: 46 💬
5Combination OF dmards----1件: 107 💬
6Conventional dmards----1件: 46 💬
7Dmards----2件: 46, 271 💬
8Dmards (methotrexate----1件: 46 💬
9Dmards or biologics----1件: 46 💬
10Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), ETC1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬
66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
11HUC-MSC + dmards----1件: 46 💬
12NON-biologic dmards----3件: 46, 86, 107 💬
13NON-biological dmards----1件: 46 💬
14Nonbiologic dmards OF investigator'S choice----1件: 46 💬
15Other dmards----1件: 46 💬
16Permitted dmards----1件: 46 💬
17Trivalent chromium versus synthetic and/ or biological dmards----1件: 46 💬
18UC-MSC+dmards----1件: 46 💬